Effect of dexamethasone and ramosetron on the prevention of postoperative nausea and vomiting in low-risk patients: a randomized, double-blind, placebo-controlled, multicenter trial

Table 4 Incidence of adverse events

Adverse effects	Group C (n = 58)	Group R (n = 58 )	Group DR (n = 58)	P value
Dizziness Headache Drowsiness	0 (0%) 5 (9%) 0 (0%)	3 (5%) 3 (5%) 0 (0%)	1 (2%) 1 (2%) 0 (0%)	0.167 0.245 0

Data presented as n (%) of patients. Patients in group C received 2 mL of intravenous 0.9% saline at the end of surgery; those in group R received 0.3 mg of intravenous ramosetron at the end of surgery, and those in group DR received 5 mg of intravenous dexamethasone at the induction of anesthesia and 0.3 mg of intravenous ramosetron at the end of surgery

ISSN: 1471-2253